SUMMARY. Dolichol and dolichyl derivatives have an important function as glycosyl carriers in the assembly of the N-asparaginyl-linked oligosaccharide core region of glycoproteins. Dolichols are synthesized through the cholesterol biosynthesis pathway in all mammalian organs and are present in all tissues, and are also associated with lipoproteins in the blood circulation. However, the origin and metabolic pathway of blood dolichols remain unknown. Abetalipoproteinaemia is a disorder of the secretion of very low-density lipoprotein (VLDL) from the liver and of chylomicrons from the intestine into the blood circulation. Therefore, examination of blood dolichols in this disorder may provide valuable information on their origin and metabolic pathway. Dolichols were exclusively associated with the high-density lipoprotein (HDL) fraction (80·7±6·3% of total dolichols) in control human blood. Serum from a patient also contained dolichols in the HDL fraction (82,8% of total dolichols). The total amount of dolichols was higher in the patient (207'Ong/mL) than in the controls (106'2±22'7ng/mL, n= 14). The compositions of dolichols were very similar to each other. These results indicated that, at least in the patient with abetalipoproteinaemia, the HDL-associated dolichols were possibly derived from the liver not through other lipoproteins but through dolichol transfer protein, or were possibly taken up and carried by HDL from peripheral tissues.
INTRODUCTION
Dolichol and dolichyl derivatives, which belong to a family of polymeric lipids with the isoprene unit, have an important function as glycosyl carriers in the assembly of the N-asparaginyllinked oligosaccharide core region of glycoproteins.' Dolichols are synthesized through the cholesterol biosynthesis pathway in all mammalian organs and are present in all tissues! and also in the blood circulation.U? The origin of blood dolichols remains unknown. Dolichols have been found to be associated with lipoproteins in the blood circulation. Keenan et al? reported that after intravenous injection of radio-labelled dolichols into rats, Correspondence: Masaru Kuriyama MD. The Second Department of Internal Medicine, Fukui Medical University, 23 Shimoaizuki, Matsuoka, Fukui 910-11, Japan. E-mail: masa@fmsrsa.fukui-med.ac.jp most of the radioactivity was rapidly taken up by the high-density lipoprotein (HDL) fraction. In an in vitro study, dolichols were also found to be specifically associated with the plasma HDL fraction in human and rats.? Elmberger et al. s demonstrated that human plasma contained dolichol, dolichyl esters and dolichyl phosphate, which were mainly (about 80%) associated with the HDL fraction. On the other hand, Van Dessel et al? and Rip and Carroll" reported that the incubation of dolichols with human or rat serum in vitro resulted in the recovery of this lipid in the very low-density lipoprotein (VLDL) fraction. In the experiments of Rip and Carroll,6.7 when this dolichol-lipoprotein preparation (formed in vitro) was injected into the bloodstream of rats, the radioactivity initial1y appeared mostly in the VLDL fraction. However, 4 days after the injection, only 5% of the radioactivity could be recovered from the VLDL fraction, whereas nearly 50% was associated The classical type of abetalipoproteinaemia is a disorder characterized by the absence of VLDL, low-density lipoprotein (LDL) and chylomicrons from plasma. I I The secretion of VLDL from the liver and of chylomicrons from the intestine into blood is defective in this disorder. Therefore, examination of blood dolichols in a patient with abetalipoproteinaemia may provide valuable information on the dolichols' origin and metabolic pathway. The present study was undertaken to examine the contents and distribution of dolichols in the blood lipoprotein fractions from a patient with abetalipoproteinaemia.
The patient, who was born to nonconsanguineous parents with no family history of the disorder, had steatorrhoea at 2 months after birth. At age 6, he noticed visual impairment. On general physical examination at age 8, he was 117cm in height (-2'6SD) and 18'3kg in weight ( -2 SD) and showed bilateral degenerative retinitis pigmentosa and slight hepatomegaly. Deep tendon reflexes were generally absent, but there was no sensory disturbance and no cerebellar ataxia. Acanthocytosis of erythrocytes was observed in the peripheral blood. Serum total cholesterol (31 mg/dl.), free cholesterol (13 mg/dl.), triglycerides (16 mg/dl.) and phospholipids (32 mg/dl.) were markedly decreased. The HDL-cholesterol level was 29 rng/dl., LDL, VLDL and chylomicrons were deficient in the serum of the patient. Apolipoproteins B-100 and B-48 could not be detected on electrophoretic gel even in the serum after oral administration of a mixture of 50 g butter, 20 g egg yolk and 25 g sucrose. His parents and a sibling all showed normal serum levels of total cholesterol, triglycerides, phospholipids and apolipoprotein B. The diagnosis of abetalipoproteinaemia was based on these clinical manifestations and biochemical abnormalities. He has been described in a separate publication."
METHODS
Venous blood was collected from the patient and 14 normal controls in the fasting state. All subjects continued their usual diets. Chylomicrons (d<0'96), VLDL (0'96<d< 1'006), intermediate-density lipoprotein (IDL) (1'006 < d < 1,019), LDL (1'019<d< 1,063), HDL (1'063 -cd-c 1,21) and LPDS (1·21 <d) were fractionated by differential ultracentrifugation.
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Kuriyama et al. Dolichols were measured by the method of Yamada et al.,3 using high-performance liquid chromatography. One millilitre of the serum was diluted with an equal volume of distilled water, and then 0·25 mL of an aqueous 50% KOH solution and 3 mL of 1% pyrogallol in methanol were added successively. The mixture was heated at 70°C for 60 min and then cooled to room temperature, and then 100J.lL of the internal standard solution, 0·02%, 2,2-didecaprenylethanol (kindly provided by Eizai Pharmaceutical Company, Tsukuba, Japan) in ethanol, was added. The saponified mixture was extracted twice with 4 mL of n-hexane, and then the combined n-hexane phase was evaporated to dryness under a stream of nitrogen. A 50 J.lL aliquot of distilled tetrahydrofuran containing 200 mmol/L anthracene-9-carboxylic acid (Aldrich Chemical Company Inc, Milwaukee, WI, USA) and 200mmol/L triphenylphosphin (Sigma Chemical Company, St Louis, MO, USA) was added to the dried extract, and then 50 J.lL of 200 rnrnol/L azodicarboxylic acid diethyl ester (Aldrich Chemical Company Inc.) in tetrahydrofuran was further added. The mixture was allowed to stand at room temperature for 10min until derivatization was complete. The mixture was then evaporated to dryness under a stream of nitrogen, and the resultant residue was dissolved in 0·4 mL of distilled benzene. The benzene solution was passed through a BondElut-SI (Varian SSP, Harbor City, CA, USA) with 2·5 mL of benzene as the elution solvent. The benzene eluate was evaporated to dryness, and then the residue was dissolved in O· 5mL of ethyl acetate/acetonitrile (7: 3). The liquid chromatography apparatus used comprised a Gilson Model 307 pump, a Gilson Model 121 fluorescence detector (Gilson Medical Electronics Inc, Villiers-le-Bel, France) and a chromatogram data processor (SIC Chromatocorder 12; System Instrument Co. Ltd, Tokyo, Japan). The column used was a YMC-Pack AM-302 (150mm x 6·0mm; YMC Co. Ltd, Kyoto, Japan). The solvent was ethyl acetate-acetonitrile-water 74: 26: 2 (by volume) and the flow rate was 1·2mL/min. Fluorescence was detected with excitation at 360 nm and emission at 460 nm, and was automatically quantitated with the Chromatocorder.
RESULTS
A typical chromatogram illustrating the separation of dolichols achieved under the above conditions is shown in Fig. 1 . The serum dolichols consisted of dolichol-17, 18, 19 and 20 (the numbers are those of isoprene units). The major dolichol was dolichol-19. The total amounts of dolichols were higher in the patient than in normal controls. The distribution percentages of dolichol-17, 18, 19 and 20 were similar in the patient and normal controls (see Table 1 ). Table 2 shows the distribution of dolichols in lipoproteins fractionated from plasma of the patient and normal controls. The dolichols were specifically associated with the HDL fraction in both the normal controls (80'7%) and the patient (82'8%). In the normal controls, small amounts of dolichols were found in the VLDL, LDL and LPDS fractions. In the patient, small but significant amounts of dolichols were detected in the LDL and LPDS fractions.
DISCUSSION
Dolichol is a long-chain polyisoprenoid, the phosphorylated form of which participates in the transfer of oligosaccharide chains during Nlinked glycoprotein synthesis. The biosynthesis of dolichols proceeds along the same path as that of cholesterol up to farnesyl pyrophosphate. Therefore, 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, a powerful and widely used treatment for hypercholesterolaemia, might also block the biosynthesis of dolichols. The present study confirmed that dolichols are exclusively associated with the HDL fraction in human blood. The plasma from the patient with abetalipoproteinaemia also contained dolichols, whose composition and distribution in lipoproteins were similar to those in normal controls. The contents of dolichols were quantitatively higher in the patient than in normal controls. Abetalipoproteinaemia is a disorder of VLDL and chylomicron excretion from the liver and intestine into the bloodstream. All lipoproteins of VLDL, IDL, LDL and chylomicrons were absent in the plasma of the patient.'! The patient had significant amounts of dolichols not only in the HDL fraction but also in the LDL and LPDS fractions. Van Dessel et al. 1O reported that a dolichol transfer protein was present in human blood and might play a role in the shuttling of dolichols between VLDL and HDL. If a dolichol transfer protein is actually present in human blood, the present study suggests the following: (I) the dolichols detected in the LDL and LPDS fractions of the patient might be bound to the dolichol transfer protein; (2) the dolichol transfer protein may carry dolichols not only between VLDL and HDL, but also between HDL and peripheral tissues or several organs, including the liver; and (3) at least in the patient with abetalipoproteinaemia, the dolichols associated with HDL were not carried from VLDL. HDL plays an essential role as a carrier of cholesterol in the reverse-cholesterol pathway, i.e., HDL takes up cholesterol from the peripheral tissues and carries it to the liver.!' We suspect that in the patient with abetalipoproteinaemia, the HDL-associated dolichols were possibly derived from the liver not through VLDL but through the dolichol transfer protein, or were possibly taken up and carried by HDL from peripheral tissues. The reason for the high dolichols content in the patient will be disclosed in the future, after the origin of and metabolic pathway for blood dolichols has been physiologically clarified.
